Auriga Starts CareFusion (CFN) at Buy; More Care and Less "ConFusion"

January 26, 2012 11:23 AM EST
Get Alerts CFN Hot Sheet
Price: $59.91 --0%

Rating Summary:
    2 Buy, 10 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Auriga initiates coverage on CareFusion (NYSE: CFN) with a Buy. PT $28.00.

Auriga analyst said, "We are impressed by CFN's market leading positions in its flagship businesses -- dispensing, infusion and respiratory. We are also of the view CFN is making steady progress as it rationalizes and simplifies the business lines inherited in the 2009 spin-off from Cardinal Health (NYSE: CAH)(NR), which we expect to result in considerable operating margin expansion and ultimately, EPS growth. While the road is a long one and may be bumpy, we think long-term investors will be rewarded. Our BUY rating is based on a 14x multiple applied to our FY13 estimate of $2.00, a slight premium to our expectations for low-teens EPS growth."

For an analyst ratings summary and ratings history on CareFusion click here. For more ratings news on CareFusion click here.

Shares of CareFusion closed at $24.02 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Auriga